Panje, Cédric

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2020 | 2019

2020

Früh, M.; Panje, C.M.; Reck, M; Blackhall, F; Califano, R; Cappuzzo, F; Besse, B; Novello, S; Garrido, P; Felip, E; O'Brien, M; Paz Ares, L; de Marinis, F; Westeel, V; De Ruysscher, D; Putora, P.M. (2020). Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) - A decision-making analysis amongst European lung cancer experts. Lung cancer, 146, pp. 6-11. Elsevier 10.1016/j.lungcan.2020.03.024

Hendrickx, Alexandra; Cozzio, Antonio; Plasswilm, Ludwig; Panje, Cédric (2020). Radiotherapy for lentigo maligna and lentigo maligna melanoma - a systematic review. Radiation oncology, 15(1), p. 174. BioMed Central 10.1186/s13014-020-01615-2

Iseli, Thomas; Fischer, Galina Farina; Panje, Cédric; Glatzer, Markus; Hundsberger, Thomas; Rothermundt, Christian; Schmidt, Barbara; Sirén, Charlotta; Plasswilm, Ludwig; Putora, Paul Martin (2020). Insular Decision Criteria in Clinical Practice: Analysis of Decision-Making in Oncology. Oncology - international journal of cancer research and treatment, 98(6), pp. 438-444. Karger 10.1159/000508132

Panje, Cédric; Lupatsch, J; Barbier, M; Pardo, E; Lorez, M; Dedes, K J; Aebersold, D. M.; Plasswilm, Ludwig; Gautschi, O.; Schwenkglenks, M. (2020). A cost-effectiveness analysis of consolidation immunotherapy with durvalumab in stage III NSCLC responding to definitive radiochemotherapy in Switzerland. Annals of oncology, 31(4), pp. 501-506. Oxford University Press 10.1016/j.annonc.2020.01.007

Glatzer, Markus; Panje, Cédric; Sirén, Charlotta; Cihoric, Nikola; Putora, Paul Martin (2020). Decision Making Criteria in Oncology. Oncology - international journal of cancer research and treatment, 98(6), pp. 370-378. Karger 10.1159/000492272

2019

Panje, Cédric; Putora, Paul M.; Hundsberger, Thomas; Hottinger, Andreas F; Roelcke, Ulrich; Pesce, Gianfranco; Herrmann, Evelyn; Matter-Walstra, Klazien (2019). Impact of treatment decision algorithms on treatment costs in recurrent glioblastoma: a health economic study. Swiss medical weekly, 149, w20153. EMH Media 10.4414/smw.2019.20153

Provide Feedback